Article
Chansu Injection Improves the Respiratory Function of Severe COVID-19 Patients
2020-05-26
Abstract excerpt
Chansu and its major active constituent of bufalin have been reported to have broad-spectrum antiviral effects. This study aims to assess the efficacy of Chansu injection in treating patients with severe COVID-19. The patients diagnosed as severe or critical COVID-19 in The First People’s Hospital of Jiangxia District, Wuhan, China from February 5 to March 5, 2020 were randomly allocated in a 1:1 ratio to receive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ed4ddd62-64fe-5a07-9903-f35ae3854f48
- DOI
- 10.1101/2020.05.20.20107607
